866-997-4948(US-Canada Toll Free)

Vascular Grafts-Medical Devices Pipeline Assessment, 2019

Published By :

GlobalData

Published Date : Dec 2019

Category :

Medical Equipments

No. of Pages : 91 Pages

Vascular Grafts - Medical Devices Pipeline Assessment, 2019

Summary

GlobalData's Medical Devices sector report, Vascular Grafts - Medical Devices Pipeline Assessment, 2019" provides an overview of Vascular Grafts currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Vascular Grafts pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Vascular Grafts under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Vascular Grafts and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Vascular Grafts under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the products current stage of development, territory and estimated launch date
Table of Contents
1.1 List of Tables 5
1.2 List of Figures 7
2 Introduction 8
2.1 Vascular Grafts Overview 8
3 Products under Development 9
3.1 Vascular Grafts - Pipeline Products by Stage of Development 9
3.2 Vascular Grafts - Pipeline Products by Segment 10
3.3 Vascular Grafts - Pipeline Products by Territory 11
3.4 Vascular Grafts - Pipeline Products by Regulatory Path 12
3.5 Vascular Grafts - Pipeline Products by Estimated Approval Date 13
3.6 Vascular Grafts - Ongoing Clinical Trials 14
4 Vascular Grafts - Pipeline Products under Development by Companies 15
4.1 Vascular Grafts Companies - Pipeline Products by Stage of Development 15
4.2 Vascular Grafts - Pipeline Products by Stage of Development 17
5 Vascular Grafts Companies and Product Overview 19
5.1 Angiograft LLC Company Overview 19
5.1.1 Angiograft LLC Pipeline Products & Ongoing Clinical Trials Overview 19
5.2 Ariste Medical LLC Company Overview 20
5.2.1 Ariste Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 20
5.3 Aruga Technologies LLC Company Overview 21
5.3.1 Aruga Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 21
5.4 Biosurfaces Inc Company Overview 22
5.4.1 Biosurfaces Inc Pipeline Products & Ongoing Clinical Trials Overview 22
5.5 Cardiojustable LLC (Inactive) Company Overview 23
5.5.1 Cardiojustable LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 23
5.6 Cardiovate Company Overview 24
5.6.1 Cardiovate Pipeline Products & Ongoing Clinical Trials Overview 24
5.7 Colorado Therapeutics, LLC Company Overview 25
5.7.1 Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 25
5.8 CryoLife Inc Company Overview 26
5.8.1 CryoLife Inc Pipeline Products & Ongoing Clinical Trials Overview 26
5.9 Cytograft Tissue Engineering Inc (Inactive) Company Overview 27
5.9.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 27
5.10 DSM Biomedical BV Company Overview 29
5.10.1 DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview 29
5.11 Eqalix Inc Company Overview 30
5.11.1 Eqalix Inc Pipeline Products & Ongoing Clinical Trials Overview 30
5.12 FIT Biotech Oy Company Overview 32
5.12.1 FIT Biotech Oy Pipeline Products & Ongoing Clinical Trials Overview 32
5.13 Gel-Del Technologies, Inc. Company Overview 34
5.13.1 Gel-Del Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 34
5.14 Humacyte Inc Company Overview 35
5.14.1 Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview 35
5.15 Innovia LLC Company Overview 41
5.15.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 41
5.16 LeMaitre Vascular Inc Company Overview 42
5.16.1 LeMaitre Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 42
5.17 Merit Medical Systems Inc Company Overview 44
5.17.1 Merit Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 44
5.18 Nationwide Children's Hospital Company Overview 45
5.18.1 Nationwide Children's Hospital Pipeline Products & Ongoing Clinical Trials Overview 45
5.19 Northwestern University Company Overview 46
5.19.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 46
5.20 Peca Labs Inc Company Overview 47
5.20.1 Peca Labs Inc Pipeline Products & Ongoing Clinical Trials Overview 47
6 Vascular Grafts- Recent Developments 64
6.1 Nov 04, 2019: PQ Bypass initiates pivotal study of next-generation advancement in Stent Graft Technology for Treatment of Patients with Peripheral Artery Disease 64
6.2 Oct 30, 2019: CryoLife reports third quarter 2019 financial results 64
6.3 Oct 23, 2019: Boston Scientific announces results for third quarter 2019 65
6.4 Oct 23, 2019: LeMaitre Vascular announces Q3 2019 financial results 67
6.5 Oct 15, 2019: LifeNet Health establishes world's first dedicated regenerative medicine logistics and distribution center in Indianapolis 68
7 Appendix 88
7.1 Methodology 88
7.2 About GlobalData 91
7.3 Contact Us 91
7.4 Disclaimer 91

List of Tables
Table 1: Vascular Grafts - Pipeline Products by Stage of Development 9
Table 2: Vascular Grafts - Pipeline Products by Segment 10
Table 3: Vascular Grafts - Pipeline Products by Territory 11
Table 4: Vascular Grafts - Pipeline Products by Regulatory Path 12
Table 5: Vascular Grafts - Pipeline Products by Estimated Approval Date 13
Table 6: Vascular Grafts - Ongoing Clinical Trials 14
Table 7: Vascular Grafts Companies - Pipeline Products by Stage of Development 15
Table 8: Vascular Grafts - Pipeline Products by Stage of Development 17
Table 9: Angiograft LLC Pipeline Products & Ongoing Clinical Trials Overview 19
Table 10: Vascular Graft - Product Status 19
Table 11: Vascular Graft - Product Description 19
Table 12: Ariste Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 20
Table 13: Drug Eluting Vascular Graft - Product Status 20
Table 14: Drug Eluting Vascular Graft - Product Description 20
Table 15: Aruga Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 21
Table 16: Topograft - Product Status 21
Table 17: Topograft - Product Description 21
Table 18: Biosurfaces Inc Pipeline Products & Ongoing Clinical Trials Overview 22
Table 19: BioFunc - APC Vascular Graft - Product Status 22
Table 20: BioFunc - APC Vascular Graft - Product Description 22
Table 21: Cardiojustable LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 23
Table 22: Adjustable SPA Shunt - Product Status 23
Table 23: Adjustable SPA Shunt - Product Description 23
Table 24: Cardiovate Pipeline Products & Ongoing Clinical Trials Overview 24
Table 25: NeoVessel Vascular Graft - Product Status 24
Table 26: NeoVessel Vascular Graft - Product Description 24
Table 27: Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 25
Table 28: Xenograft Implant - Peripheral Vascular Disease - Product Status 25
Table 29: Xenograft Implant - Peripheral Vascular Disease - Product Description 25
Table 30: CryoLife Inc Pipeline Products & Ongoing Clinical Trials Overview 26
Table 31: Synergraft Xenograft Vascular Graft - Product Status 26
Table 32: Synergraft Xenograft Vascular Graft - Product Description 26
Table 33: Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 27
Table 34: Lifeline TEBV - Lower Limb - Product Status 27
Table 35: Lifeline TEBV - Lower Limb - Product Description 27
Table 36: LifeLine TEBV - Pediatric - Product Status 28
Table 37: LifeLine TEBV - Pediatric - Product Description 28
Table 38: DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview 29
Table 39: Small Diameter Vascular Graft - Product Status 29
Table 40: Small Diameter Vascular Graft - Product Description 29
Table 41: Eqalix Inc Pipeline Products & Ongoing Clinical Trials Overview 30
Table 42: CardioVessel - Product Status 30
Table 43: CardioVessel - Product Description 30
Table 44: LCL Graft - Product Status 31
Table 45: LCL Graft - Product Description 31
Table 46: FIT Biotech Oy Pipeline Products & Ongoing Clinical Trials Overview 32
Table 47: GTU X-Graft - Product Status 32
Table 48: GTU X-Graft - Product Description 32
Table 49: GTU X2-Graft - Product Status 33
Table 50: GTU X2-Graft - Product Description 33
Table 51: Gel-Del Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 34
Table 52: VasoGraft - Product Status 34
Table 53: VasoGraft - Product Description 34
Table 54: Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview 35
Table 55: HUMACYL - Peripheral Artery Disease - Product Status 35
Table 56: HUMACYL - Peripheral Artery Disease - Product Description 35
Table 57: HUMACYL Graft - CABG - Product Status 36
Table 58: HUMACYL Graft - CABG - Product Description 36
Table 59: HUMACYL Graft - Vascular Trauma - Product Status 36
Table 60: HUMACYL Graft - Vascular Trauma - Product Description 37
Table 61: Humacyte Inc - Ongoing Clinical Trials Overview 38
Table 62: HUMACYL Graft - Vascular Trauma - A Phase II Study for the Evaluation of Safety and Efficacy of Humacyte's Human Acellular Vessel for Vascular Replacement or Reconstruction in Patients with Life or Limb-threatening Vascular Trauma 39
Table 63: HUMACYL - Peripheral Artery Disease - A Phase II Study for the Evaluation of Safety and Efficacy of Humacyte's Human Acellular Vessel for Use as a Vascular Prosthesis for Femoro-popliteal Bypass in Patients with Peripheral Arterial Disease 40
Table 64: Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 41
Table 65: 4mm Vascular Graft - Product Status 41
Table 66: 4mm Vascular Graft - Product Description 41
Table 67: LeMaitre Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 42
Table 68: LifeSpan ePTFE Vascular Graft - Product Status 42

List of Figures
Figure 1: Vascular Grafts - Pipeline Products by Stage of Development 9
Figure 2: Vascular Grafts - Pipeline Products by Segment 10
Figure 3: Vascular Grafts - Pipeline Products by Territory 11
Figure 4: Vascular Grafts - Pipeline Products by Regulatory Path 12
Figure 5: Vascular Grafts - Pipeline Products by Estimated Approval Date 13
Figure 6: Vascular Grafts - Ongoing Clinical Trials 14

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *